Editas Medicine, Inc. (EDIT) CEO James Mullen Presents at JPMorgan 40th Annual Healthcare Conference (Transcript) [Seeking Alpha]
Editas Medicine, Inc. (EDIT)
Last editas medicine, inc. earnings: 2/26 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.editasmedicine.com
Company Research
Source: Seeking Alpha
Editas Medicine, Inc.(NASDAQ:EDITCompany ParticipantsJames Mullen - Chairman and CEOMark Shearman - Chief Scientific OfficerLisa Michaels - Chief Medical OfficerConference Call ParticipantsCory Kasimov - JPMorganGreat, good morning everyone from the 40th Annual JPMorgan Conference. My name is Cory Kasimov. I'm the senior large cap biotech analyst and it's my pleasure to introduce Editas Medicine, and Chairman and CEO, Jim Mullen. Please note that following the presentation, we will move right into a Q&A session where you can send in your questions via the conference portal. And I'll do my best to work them into the conversation.So with that, Jim thanks as always, for joining us today. And let me turn things over to you for an update on Editas.Thank you, Cory for the introduction. And to everyone welcome to the Editas Medicine presentation. I was appointed as CEO months ago, and at that time I had a few objectives. The first was to assess our science and the evolution of the science i
Show less
Read more
Impact Snapshot
Event Time:
EDIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDIT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDIT alerts
High impacting Editas Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
EDIT
News
- Editas Medicine Announces First Quarter 2024 Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Editas Medicine Announces First Quarter 2024 Results and Business UpdatesGlobeNewswire
- Experimental gene therapy restores some vision in patients with inherited blindness [CNN]CNN
- Experimental gene therapy restores some vision in patients with inherited blindness [CNN]CNN
- Editas Medicine, Inc. (NASDAQ:EDIT) is a favorite amongst institutional investors who own 71% [Yahoo! Finance]Yahoo! Finance
EDIT
Earnings
- 5/8/24 - Miss
EDIT
Sec Filings
- 5/8/24 - Form 10-Q
- 5/8/24 - Form 8-K
- 4/16/24 - Form DEFA14A
- EDIT's page on the SEC website